Vaginal laxity
Conditions
Interventions
Experimental group:Utilize pelvic floor magnetic stimulation combined with pelvic floor rehabilitation training
Control group:Carrying out pelvic floor rehabilitation training alone
Sponsors
Qinghai Red Cross Hospital
Eligibility
Sex/Gender
Female
Age
22 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for vaginal laxity disorder (refer to the 2024 "Diagnostic and Treatment Specifications for Female Vaginal Laxity" group standard); 2. Has a history of sexual life, without severe complications related to menopause; 3. Has not received pelvic floor rehabilitation treatment (rehabilitation training, pelvic floor magnetic stimulation therapy, electrical stimulation, CO2 laser treatment) or pelvic floor surgery (vaginal tightening surgery, pelvic floor reconstruction surgery) within the past 6 months; 4. Can understand and cooperate with the treatment process and all evaluations (accurately perform Kegel training movements, cooperate with questionnaire filling, and receive follow-up visits on time); 5. Has no severe functional disorders of important organs, no abnormal coagulation function; 6. Is not pregnant or lactating, and has no fertility plans within the past 6 months (to avoid the interference of pregnancy on pelvic floor function and affect the judgment of therapeutic effect); 7. The patient consents to participate in this study voluntarily and signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those with severe diseases of important organs such as the heart, liver, and kidneys; 2. Those with neurological disorders (spinal cord injury, multiple sclerosis, myasthenia gravis) that result in incomplete or complete loss of nerve control of the pelvic floor muscles; 3. Those who are pregnant or breastfeeding; 4. Those who have recently undergone pelvic floor surgery, vaginal tightening surgery, or other pelvic floor treatment; 5. Those with mental disorders (anxiety disorder, depression) or cognitive impairments that affect the assessment of subjective symptoms, and who are unable to cooperate with treatment and assessment; 6. Those with metal implants in the pelvic cavity (except for intrauterine contraceptive devices, artificial joints, and steel plates), as magnetic stimulation may cause metal displacement and tissue damage; 7. Those with acute pelvic inflammation (vaginitis, cervicitis, pelvic inflammation) in the acute stage, or with damaged external genitalia and vaginal skin, and whose treatment may aggravate the condition; 8. Those with other functional disorders of the pelvic floor (moderate to severe stress urinary incontinence, pelvic organ prolapse grade II or above), which may interfere with the judgment of therapeutic effect; 9. Those with malignant tumors (gynecological tumors, pelvic tumors) or a history of tumor radiotherapy or chemotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic Floor Three-Dimensional Ultrasound;Pelvic Floor Type I and Type II Muscle Fiber Strength; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual Function Index;Vaginal Laxity Degree (Finger Assessment Method);Vaginal Health Index Score;Surface Electromyography;Vaginal Laxity Questionnaire;Vaginal Manometry; | — |
Countries
China
Contacts
Public ContactLiehong Wang
Qinghai Red Cross Hospital
Outcome results
None listed